BioNTech SE (WBO:BNTX) Other Operating Expense : €-23 Mil (TTM As of Mar. 2024)

View and export this data going back to 2020. Start your Free Trial

What is BioNTech SE Other Operating Expense?

BioNTech SE's Other Operating Expense for the three months ended in Mar. 2024 was €-4 Mil. Its Other Operating Expense for the trailing twelve months (TTM) ended in Mar. 2024 was €-23 Mil.

BioNTech SE's quarterly Other Operating Expense declined from Sep. 2023 (€3 Mil) to Dec. 2023 (€-25 Mil) but then increased from Dec. 2023 (€-25 Mil) to Mar. 2024 (€-4 Mil).

BioNTech SE's annual Other Operating Expense increased from Dec. 2021 (€-138 Mil) to Dec. 2022 (€-66 Mil) and increased from Dec. 2022 (€-66 Mil) to Dec. 2023 (€-26 Mil).

BioNTech SE Other Operating Expense Historical Data

The historical data trend for BioNTech SE's Other Operating Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

BioNTech SE Other Operating Expense Chart

BioNTech SE Annual Data

Trend

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Other Operating Expense

Get a 7-Day Free Trial

2.90

-248.10

-138.30

-66.40

-25.80

BioNTech SE Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Other Operating Expense	Get a 7-Day Free Trial															68.60	3.30	2.90	-25.30	-4.40

BioNTech SE Other Operating Expense Calculation

GuruFocus uses a standardized financial statement format for all companies. For non-financial companies, GuruFocus lists Selling, General, & Admin. Expense, , Research & Development, and Other Operating Expense under the "Total Operating Expense" section.

Other Operating Expense sometimes includes:
Restructuring, and merger
Acquisition related and other
Litigation settlement charge
Other (too numerous to list)

Some companies can and do choose to report each of these items separately. Yet, there are a variety of Other Operating Expense which are simply too numerous to list.

Other Operating Expense for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was €-23 Mil.

BioNTech SE Other Operating Expense Related Terms

Thank you for viewing the detailed overview of BioNTech SE's Other Operating Expense provided by GuruFocus.com. Please click on the following links to see related term pages.

BioNTech SE (WBO:BNTX) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » BioNTech SE (WBO:BNTX) » Definitions » Other Operating Expense

Comparable Companies

Traded in Other Exchanges

BNTX:USA BNTX:Mexico 0A3M:UK 22UA:Germany B1NT34:Brazil

Address

An der Goldgrube 12, Mainz, RP, DEU, D-55131

Website

https://www.biontech.de

BioNTech is a Germany-based biotechnology company that focuses on developing cancer therapeutics, including individualized immunotherapy, as well as vaccines for infectious diseases, including COVID-19. The company's oncology pipeline contains several classes of drugs, including mRNA-based drugs to encode antigens, neoantigens, cytokines, and antibodies; cell therapies; bispecific antibodies; and small-molecule immunomodulators. BioNTech is partnered with several large pharmaceutical companies, including Roche, Eli Lilly, Pfizer, Sanofi, and Genmab. COVID-19 vaccine Comirnaty is its first commercialized product.